Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

Table 2 The demographic and clinical features of all subjects in this investigation

	Subjects			P value
	HBsAg seroclearance (n = 14)	Immunotolerant HBV carrier (n = 7)	Inactive HBsAg carrier (n = 9)
Age(yrs) Median/Range	38/21~58	23/20~36	25/22~34	0.002^a
Gender Male/Female	11/3	5/2	5/4	0.499^b
ALT(U/L) Median/Range	22/13~60	33/20~39	21/9~39	0.144^a
HBV DNA (Log₁₀ copies/mL) Mean ± SD	undetectable^c	7.05 ± 0.66	undetectable^c

Note. ^a Kruskal-Wallis H test; ^b Fisher's exact test; ^c HBV DNA undetectable by real-time PCR

ISSN: 1743-422X